Literature DB >> 2419145

Apparent enhancement of cholinergic transmission in rabbit bronchi via adenosine A2 receptors.

L E Gustafsson, N P Wiklund, B Cederqvist.   

Abstract

Adenosine and its derivatives enhanced the contractile responses to transmural nerve stimulation in rabbit isolated bronchial smooth muscle. 5'-N-Ethylcarboxamideadenosine (NECA) was the most potent adenosine analogue studied. Enhancement of contractile responses by NECA was competitively antagonized by 8-p-sulfophenyltheophylline. Guanethidine, mepyramine, capsaicin or eicosatetraynoic acid did not antagonize the enhancement elicited by adenosine or NECA. NECA did not enhance the contractile responses to exogenously applied acetylcholine or contractile responses elicited after administration of tetrodotoxin. We suggest that adenosine, via an action at A2 receptors, enhances contractile responses to nerve stimulation in rabbit bronchial muscle. Methylxanthines are competitive antagonists at these extracellular receptors. The enhancement probably involves a sodium-dependent mechanism but not adrenergic mechanisms or release of histamine, substance P or arachidonate metabolites. The enhancement indicates increased cholinergic transmitter release or action, but release of a secondary spasmogenic or decreased release of an inhibitor mediator cannot be excluded. The results may indicate a role for adenosine in asthma.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2419145     DOI: 10.1016/0014-2999(86)90538-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  12 in total

1.  Characterization of adenosine receptors involved in adenosine-induced bronchoconstriction in allergic rabbits.

Authors:  A el-Hashim; B D'Agostino; M G Matera; C Page
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

Review 2.  Adenosine bronchoconstriction in asthma: investigations into its possible mechanism of action.

Authors:  W H Ng; R Polosa; M K Church
Journal:  Br J Clin Pharmacol       Date:  1990       Impact factor: 4.335

3.  Adenosine in heart and lung disease. Proceedings of the first Cardiothoracic Institute Workshop. 30 March 1988, London. Abstracts.

Authors: 
Journal:  Postgrad Med J       Date:  1988-10       Impact factor: 2.401

4.  Effects of dexamethasone on airway hyper-responsiveness to the adenosine A1 receptor agonist cyclo-pentyl adenosine in an allergic rabbit model.

Authors:  A Z El-Hashim; K H Banner; W Paul; C P Page
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

5.  Adenosine enhancement of adrenergic neuroeffector transmission in guinea-pig pulmonary artery.

Authors:  N P Wiklund; B Cederqvist; L E Gustafsson
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

6.  Adenosine monophosphate and histamine induced bronchoconstriction: repeatability and protection by terbutaline.

Authors:  E Egbagbe; I D Pavord; P Wilding; J Thompson-Coon; A E Tattersfield
Journal:  Thorax       Date:  1997-03       Impact factor: 9.139

Review 7.  Release and actions of adenosine in the central nervous system.

Authors:  M J Higgins; H Hosseinzadeh; D G MacGregor; H Ogilvy; T W Stone
Journal:  Pharm World Sci       Date:  1994-04-15

8.  Adenosine modulation of resting vascular tone in rabbit skeletal muscle.

Authors:  L E Gustafsson; M G Persson; A Ohlén; P Hedqvist; L Lindbom
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-05       Impact factor: 3.000

9.  Influence of aminophylline and 8-(p-sulfophenyl)theophylline on the anticonvulsive action of diphenylhydantoin, phenobarbital, and valproate against maximal electroshock-induced convulsions in mice.

Authors:  K Borowicz; M Kozicka; Z Kleinrok; S J Czuczwar
Journal:  J Neural Transm Gen Sect       Date:  1993

10.  A study of the actions of P1-purinoceptor agonists and antagonists in the mouse vas deferens in vitro.

Authors:  A G Blakeley; P M Dunn; S A Petersen
Journal:  Br J Pharmacol       Date:  1988-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.